Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?

Simple item page
dc.contributor.authorEinhorn, Lawrence H.
dc.contributor.authorAdra, Nabil
dc.contributor.authorHanna, Nasser
dc.contributor.authorNichols, Craig
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2021-09-21T20:25:34Z
dc.date.available2021-09-21T20:25:34Z
dc.date.issued2020-09
dc.eprint.versionFinal published versionen_US
dc.identifier.citationEinhorn, L. H., Adra, N., Hanna, N., & Nichols, C. (2020). Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option? Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 38(26), 3073–3074. https://doi.org/10.1200/JCO.20.00702en_US
dc.identifier.urihttps://hdl.handle.net/1805/26634
dc.language.isoenen_US
dc.publisherASCOen_US
dc.relation.isversionof10.1200/JCO.20.00702en_US
dc.relation.journalJournal of Clinical Oncologyen_US
dc.sourcePublisheren_US
dc.subjectadjuvant chemotherapyen_US
dc.subjectadjuvant etoposide plus cisplatinen_US
dc.titleAdjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Einhorn2020Adjuvant.pdf
Size:
530.94 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Medicine Works